Hospital News and Research

RSS

NREF supports new post-residency fellowship grant program

The NREF has reached an agreement with Codman & Shurtleff, Inc. to provide funding to the NREF in support of the Foundation's new post-residency fellowship grant program.

16 Dec 2009

Rib-X Pharmaceuticals and MGH enter into collaborative research agreement

Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections announced today it has entered into a collaborative research agreement with Massachusetts General Hospital (MGH).

16 Dec 2009

TRAPPC9 as gene may be associated with intellectual disability world-wide, scientists identify

A gene involved in some forms of intellectual disability has been identified by scientists at the Centre for Addiction and Mental Health (CAMH), as published this month in The American Journal of Human Genetics. The gene is called TRAPPC9.

16 Dec 2009

Carrier screening reduces CF birth rates in northeast Italy

An increase in the number of screened carriers for cystic fibrosis (CF) was associated with a decrease in the number of children born with CF in northeast Italy, according to a study in the December 16 issue of JAMA.

16 Dec 2009

BioAlliance Pharma SA to enter Phase II clinical trial for clonidine Lauriad and Phase I clinical trial for AMEP

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.

15 Dec 2009

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Genocea Biosciences, a leading vaccine discovery and development company, today announced it has been awarded a grant from the University of Pittsburgh Medical Center’s (UPMC) Sexually Transmitted Infections (STI) Cooperative Research Center for the development of vaccines for Chlamydia trachomatis.

15 Dec 2009

CALSTAR 6 recognised with the "Thermal Angel Lifesaver of the Year Award"

Estill Medical Technologies, Inc., a family-owned Texas company that produces the Thermal Angel Blood and IV Fluid Infusion Warmer, a patented medical device being utilized by U.S. hospitals, military and emergency responders to lessen the effects of fluid-induced hypothermia, named the CALSTAR 6 Unit of South Lake Tahoe as the first-ever recipient of their "Thermal Angel Lifesaver of the Year Award."

15 Dec 2009

VA struggles to provide better care for increasing numbers of younger, female veterans

New patients using Veterans Affairs health services are more likely to be younger and women. The Associated Press reports on a Veterans Affairs Medical Center in Martinsville, W.Va., that is increasingly seeing women in their twenties who served in Iraq and Afghanistan. "The hospital sees nearly twice as many women it did before the Sept. 11 attacks.

15 Dec 2009

Cellular and subcellular effects of PACE technology presented

SANUWAVE Health, Inc., (www.sanuwave.com), an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, announced that the cellular and subcellular effects of PACE™ technology were described during a lecture presented this past weekend.

15 Dec 2009

Lytix Biopharma AS receives approval to commence Phase I clinical trials of Oncopore

The Norwegian pharmaceutical company Lytix Biopharma AS today announced approvals from the Norwegian Medicines Agency (”Statens legemiddelverk”) and the Swedish Medical Products Agency (”Läkemedelverket”) to commence Phase I clinical trials of OncoporeTM (LTX-315) for the treatment of cancer.

15 Dec 2009

QLT commences enrollment in QLT091001 Phase Ib trial of LCA pediatric patients

QLT Inc. today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in pediatric patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.

15 Dec 2009

RMHC reports grants awarded in 2009

Ronald McDonald House Charities (RMHC®) of the Philadelphia Region, Inc. today announced that more than $290,000 in grants has been awarded to local nonprofit organizations throughout 2009. These grants provided support to programs aimed at improving the health and well-being of children throughout the Greater Philadelphia Region.

15 Dec 2009

Pure populations of immature cells that enable male reproduction isolated and transplanted

Reproductive researchers from the University of Pennsylvania and The Children's Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species-human spermatogonia and mouse gonocytes. These germline stem cells, taken from testis biopsies, demonstrated viability following transplantation to mouse testes within a controlled laboratory setting.

15 Dec 2009

Risks and benefits of CT scans

Doses of radiation from commonly performed computed tomography (CT) scans vary widely, appear higher than generally believed and may contribute to an estimated tens of thousands of future cancer cases, according to two reports in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Dec 2009

Doctors measure the positive effects of Under Johnnies on patients' comfort during hospital stay

OBP Medical Inc. declares victory in the battle for improved comfort and overall patient satisfaction in hospitals.

15 Dec 2009

Findings suggest variations in accelerated aging disorders

UT Southwestern Medical Center researchers have provided the most extensive account to date of the unique observable characteristics seen in patients with an extremely rare premature aging syndrome.

15 Dec 2009

Tendons control bone formation that leads to strong skeletal system

In all vertebrates, including humans, bones, muscles and tendons work together to give the skeleton its characteristic balance of stability and movement. Now, new research uncovers a previously unrecognized interaction between tendons, which connect muscles to bones, and the developing embryonic skeleton.

15 Dec 2009

Florida doctor performs new, effective treatment for sinusitis

Local physician William Laskowski, MD has become the first doctor in Florida to perform an effective new treatment for sinusitis called FinESS® Sinus Treatment in an office setting. FinESS® (Entellus Medical, Maple Grove, MN) is a balloon sinuplasty option that is less-invasive than traditional sinus surgery and breaks the cycle of chronic or recurrent sinusitis with immediate relief and lasting results.

15 Dec 2009

Haemonetics alleges continued patent infringement by Fenwal, files a new lawsuit

Haemonetics Corporation announced today that it has filed a new legal action to stop Fenwal Inc.'s continued patent infringement resulting from Fenwal's just released red cell collection kits, using a modified separation chamber. Fenwal allegedly modified its separation chamber to circumvent Haemonetics' patent and the injunction entered by the Court prohibiting Fenwal's continued sale of infringing products after December 1, 2010.

15 Dec 2009

OU lab completes studies on new type of training technique

Bemben's lab at the university is currently only one of four labs outside of Japan that has been working with the KAATSU-Master training system, testing the effectiveness of reducing blood flow to exercising muscle.

15 Dec 2009

Hospital News and Research

NREF supports new post-residency fellowship grant program

Rib-X Pharmaceuticals and MGH enter into collaborative research agreement

TRAPPC9 as gene may be associated with intellectual disability world-wide, scientists identify

Carrier screening reduces CF birth rates in northeast Italy

BioAlliance Pharma SA to enter Phase II clinical trial for clonidine Lauriad and Phase I clinical trial for AMEP

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

CALSTAR 6 recognised with the "Thermal Angel Lifesaver of the Year Award"

VA struggles to provide better care for increasing numbers of younger, female veterans

Cellular and subcellular effects of PACE technology presented

Lytix Biopharma AS receives approval to commence Phase I clinical trials of Oncopore

QLT commences enrollment in QLT091001 Phase Ib trial of LCA pediatric patients

RMHC reports grants awarded in 2009

Pure populations of immature cells that enable male reproduction isolated and transplanted

Risks and benefits of CT scans

Doctors measure the positive effects of Under Johnnies on patients' comfort during hospital stay

Findings suggest variations in accelerated aging disorders

Tendons control bone formation that leads to strong skeletal system

Florida doctor performs new, effective treatment for sinusitis

Haemonetics alleges continued patent infringement by Fenwal, files a new lawsuit

OU lab completes studies on new type of training technique

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News